Paper8856046
Gangliosides block antigen presentation by human monocytes.
Heitger A and 1 other. Biochim Biophys Acta, 1996. Cited by 52 papers, by iCite.
Cite this record
ConductScience Library. Gangliosides block antigen presentation by human monocytes. Papers, record 8856046. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8856046
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Publication types
- Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.
- PubMed
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antigen Presentation | Major topic |
| Gangliosides | Major topic |
| Immunosuppressive Agents | Major topic |
| Monocytes | Major topic |
| Antigens | |
| Brain Chemistry | |
| Humans | |
| Lymphocyte Activation | |
| Peptide Fragments | |
| T-Lymphocyte Subsets | |
| Tetanus Toxoid |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| CA42361 | NCI NIH HHS | United States | R01CA042361 | PubMed and NIH | NIH RePORTER |
| CA61010 | NCI NIH HHS | United States | R01CA061010 | PubMed and NIH | NIH RePORTER |
Cited by19
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 52 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 39628991 | When a negative (charge) is not a positive: sialylation and its role in cancer mechanics and progression. | Front Oncol | 2024 | https://conductscience.org/library/papers/39628991 | PubMed |
| 39051512 | Dysfunction of dendritic cells in tumor microenvironment and immunotherapy. | Cancer Commun (Lond) | 2024 | https://conductscience.org/library/papers/39051512 | PubMed |
| 35372499 | Role of Globotriaosylceramide in Physiology and Pathology. | Front Mol Biosci | 2022 | https://conductscience.org/library/papers/35372499 | PubMed |
| 33133075 | Aiming for the Sweet Spot: Glyco-Immune Checkpoints and γδ T Cells in Targeted Immunotherapy. | Front Immunol | 2020 | https://conductscience.org/library/papers/33133075 | PubMed |
| 31874115 | Don't sugarcoat it: How glycocalyx composition influences cancer progression. | J Cell Biol | 2020 | https://conductscience.org/library/papers/31874115 | PubMed |
| 30761148 | The Role of Glycosphingolipids in Immune Cell Functions. | Front Immunol | 2019 | https://conductscience.org/library/papers/30761148 | PubMed |
| 29402391 | IFN-γ and tumor gangliosides: Implications for the tumor microenvironment. | Cell Immunol | 2018 | https://conductscience.org/library/papers/29402391 | PubMed |
| 28032600 | The function of cancer-shed gangliosides in macrophage phenotype: involvement with angiogenesis. | Oncotarget | 2017 | https://conductscience.org/library/papers/28032600 | PubMed |
| 26779443 | Dysregulated Expression of Glycolipids in Tumor Cells: From Negative Modulator of Anti-tumor Immunity to Promising Targets for Developing Therapeutic Agents. | Front Oncol | 2015 | https://conductscience.org/library/papers/26779443 | PubMed |
| 26226135 | GBM Derived Gangliosides Induce T Cell Apoptosis through Activation of the Caspase Cascade Involving Both the Extrinsic and the Intrinsic Pathway. | PLoS One | 2015 | https://conductscience.org/library/papers/26226135 | PubMed |
| 24348482 | The dark side of dendritic cells: development and exploitation of tolerogenic activity that favor tumor outgrowth and immune escape. | Front Immunol | 2013 | https://conductscience.org/library/papers/24348482 | PubMed |
| 19276353 | GD3, an overexpressed tumor-derived ganglioside, mediates the apoptosis of activated but not resting T cells. | Cancer Res | 2009 | https://conductscience.org/library/papers/19276353 | PubMed |
| 17571260 | Dynamic cross-talk between tumor and immune cells in orchestrating the immunosuppressive network at the tumor microenvironment. | Cancer Immunol Immunother | 2007 | https://conductscience.org/library/papers/17571260 | PubMed |
| 12902465 | Mechanisms of ganglioside inhibition of APC function. | J Immunol | 2003 | https://conductscience.org/library/papers/12902465 | PubMed |
| 12452834 | Gangliosides inhibit the development from monocytes to dendritic cells. | Clin Exp Immunol | 2002 | https://conductscience.org/library/papers/12452834 | PubMed |
| 12060764 | Inhibition of glycolipid shedding rescues recognition of a CD1+ T cell lymphoma by natural killer T (NKT) cells. | Proc Natl Acad Sci U S A | 2002 | https://conductscience.org/library/papers/12060764 | PubMed |
| 11982587 | Ganglioside expression in tissues of mice lacking beta2-microglobulin. | Clin Exp Immunol | 2002 | https://conductscience.org/library/papers/11982587 | PubMed |
| 10491412 | Renal cell carcinoma-derived gangliosides suppress nuclear factor-kappaB activation in T cells. | J Clin Invest | 1999 | https://conductscience.org/library/papers/10491412 | PubMed |
| 9728328 | Sphingolipids and cell signalling. | J Inherit Metab Dis | 1998 | https://conductscience.org/library/papers/9728328 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/8856046
GET https://conductscience.org/api/papers/v1/8856046/authors